BNP Paribas Financial Markets
RVMD icon

BNP Paribas Financial Markets’s Revolution Medicines RVMD Stock Holding History

BNP Paribas Financial Markets’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104M Buy
552,710
+130,267
+31% +$19M 0.04% 438
2026
Q1 		$41.1M Sell
422,443
-196,944
-32% -$19.9M 0.02% 776
2025
Q4 		$49.3M Buy
619,387
+194,706
+46% +$12.8M 0.02% 691
2025
Q3 		$19.8M Buy
424,681
+57,336
+16% +$2.24M 0.01% 1127
2025
Q2 		$13.5M Sell
367,345
-157,083
-30% -$6.03M 0.01% 1247
2025
Q1 		$18.5M Buy
524,428
+276,102
+111% +$11.2M 0.01% 1087
2024
Q4 		$10.9M Buy
+248,326
New +$12.5M 0.01% 1310

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BNP Paribas Financial Markets's RVMD Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Revolution Medicines (RVMD) stake by 31% in Q2 2026, buying an estimated $19M and bringing the position to 552,710 shares worth $104M. The position accounts for 0.04% of the portfolio, ranked #438.

BNP Paribas Financial Markets first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • BNP Paribas Financial Markets held 552,710 shares of Revolution Medicines worth $104M as of Q2 2026.
  • BNP Paribas Financial Markets bought 130,267 Revolution Medicines shares in Q2 2026, an estimated $19M.
  • Revolution Medicines made up 0.04% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #438 holding.
  • BNP Paribas Financial Markets first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.